These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 15892401

  • 1. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST).
    Weber EW, Slappendel R, Hémon Y, Mähler S, Dalén T, Rouwet E, van Os J, Vosmaer A, van der Ark P.
    Eur J Anaesthesiol; 2005 Apr; 22(4):249-57. PubMed ID: 15892401
    [Abstract] [Full Text] [Related]

  • 2. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with preoperative autologous blood donation in total joint arthroplasty.
    Stowell CP, Chandler H, Jové M, Guilfoyle M, Wacholtz MC.
    Orthopedics; 1999 Jan; 22(1 Suppl):s105-12. PubMed ID: 9927110
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy.
    Cortesi E, Mancuso A, De Pasquale Ceratti A, Pizzardi N, D'Auria G, Accettura C, Beccaglia P, Bertelletti D, De Marinis F.
    Oncologist; 2004 Jan; 9(4):459-68. PubMed ID: 15266099
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of epoetin alfa in critically ill patients.
    Corwin HL, Gettinger A, Fabian TC, May A, Pearl RG, Heard S, An R, Bowers PJ, Burton P, Klausner MA, Corwin MJ, EPO Critical Care Trials Group.
    N Engl J Med; 2007 Sep 06; 357(10):965-76. PubMed ID: 17804841
    [Abstract] [Full Text] [Related]

  • 5. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
    Stovall TG.
    J Reprod Med; 2001 May 06; 46(5 Suppl):531-8. PubMed ID: 11396387
    [Abstract] [Full Text] [Related]

  • 6. An open-label, randomized, multicenter, controlled study of epoetin alfa for the treatment of anemia of chronic kidney disease in the long term care setting.
    Patel M, Thimons DG, Winston JL, Langholff W, McGowan T.
    J Am Med Dir Assoc; 2012 Mar 06; 13(3):244-8. PubMed ID: 21450214
    [Abstract] [Full Text] [Related]

  • 7. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
    Santini D, Vincenzi B, La Cesa A, Virzi V, Navajas F, Malafarina V, Dicuonzo G, Cassandro R, Esposito V, Montesarchio V, Groeger AM, Tonini G.
    Anticancer Res; 2005 Mar 06; 25(1B):669-74. PubMed ID: 15816644
    [Abstract] [Full Text] [Related]

  • 8. Preoperative administration of epoetin alfa to reduce transfusion requirements in elderly patients having primary total hip or knee reconstruction.
    Lofthouse RA, Boitano MA, Davis JR, Jinnah RH.
    J South Orthop Assoc; 2000 Mar 06; 9(3):175-81. PubMed ID: 12135299
    [Abstract] [Full Text] [Related]

  • 9. Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial.
    Wilkinson PM, Antonopoulos M, Lahousen M, Lind M, Kosmidis P, EPO-INT-45 Study Group.
    Br J Cancer; 2006 Apr 10; 94(7):947-54. PubMed ID: 16570051
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of epoetin alfa in a retrospective non-stratified subgroup analysis of a breast cancer cohort receiving non-platinum chemotherapy.
    Bajetta E, Vercammen E, Reinhardt U, Janmohamed R, da Costa RM, Matulonis U, Guastalla JP, Epoetin Alfa Study Group.
    Tumori; 2004 Apr 10; 90(5):449-57. PubMed ID: 15656327
    [Abstract] [Full Text] [Related]

  • 11. PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study.
    Lasocki S, Krauspe R, von Heymann C, Mezzacasa A, Chainey S, Spahn DR.
    Eur J Anaesthesiol; 2015 Mar 10; 32(3):160-7. PubMed ID: 25564780
    [Abstract] [Full Text] [Related]

  • 12. The predictive power of baseline hemoglobin for transfusion risk in surgery patients.
    Faris PM, Spence RK, Larholt KM, Sampson AR, Frei D.
    Orthopedics; 1999 Jan 10; 22(1 Suppl):s135-40. PubMed ID: 9927114
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R, Epoetin Zeta Study Group.
    Curr Med Res Opin; 2008 Mar 10; 24(3):625-37. PubMed ID: 18208642
    [Abstract] [Full Text] [Related]

  • 14. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
    Scott SN, Boeve TJ, McCulloch TM, Fitzpatrick KA, Karnell LH.
    Laryngoscope; 2002 Jul 10; 112(7 Pt 1):1221-9. PubMed ID: 12169903
    [Abstract] [Full Text] [Related]

  • 15. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
    Quirt I, Kovacs M, Couture F, Turner AR, Noble M, Burkes R, Dolan S, Plante RK, Lau CY, Chang J.
    Oncologist; 2006 Jan 10; 11(1):73-82. PubMed ID: 16401716
    [Abstract] [Full Text] [Related]

  • 16. Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial.
    Reed SD, Radeva JI, Daniel DB, Mody SH, Forlenza JB, McKenzie RS, Schulman KA.
    Pharmacoeconomics; 2006 Jan 10; 24(5):479-94. PubMed ID: 16706573
    [Abstract] [Full Text] [Related]

  • 17. Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.
    Afdhal NH, Dieterich DT, Pockros PJ, Schiff ER, Shiffman ML, Sulkowski MS, Wright T, Younossi Z, Goon BL, Tang KL, Bowers PJ, Proactive Study Group.
    Gastroenterology; 2004 May 10; 126(5):1302-11. PubMed ID: 15131791
    [Abstract] [Full Text] [Related]

  • 18. Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies.
    Henry DH.
    Drugs; 2007 May 10; 67(2):175-94. PubMed ID: 17284083
    [Abstract] [Full Text] [Related]

  • 19. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial.
    Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC, Whitsitt P, Wheeler SL, Lau CY.
    Ann Intern Med; 2000 Dec 05; 133(11):845-54. PubMed ID: 11103054
    [Abstract] [Full Text] [Related]

  • 20. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients.
    de Andrade JR, Jove M, Landon G, Frei D, Guilfoyle M, Young DC.
    Am J Orthop (Belle Mead NJ); 1996 Aug 05; 25(8):533-42. PubMed ID: 8871751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.